| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/02/2004 | EP1423405A2 Plasmodium falciparum ama-1 protein and uses thereof |
| 06/02/2004 | EP1423403A2 13 human secreted proteins |
| 06/02/2004 | EP1423402A2 Novel polypeptide analogs and fusions and their methods of use |
| 06/02/2004 | EP1423401A2 Lp354 mammalian secreted protein |
| 06/02/2004 | EP1423176A2 Method and apparatus for removal of insulin binding proteins (ibp) from biological fluids |
| 06/02/2004 | EP1423143A2 Crystal forms and mutants of rank ligand |
| 06/02/2004 | EP1423140A2 Compositions and methods for modulation of immune responses |
| 06/02/2004 | EP1423139A2 New use of artemin, a member of the gdnf ligand family |
| 06/02/2004 | EP1423136A1 Polypeptide conjugates with extended circulating half-lives |
| 06/02/2004 | EP1423135A2 Methods for inhibiting angiogenesis |
| 06/02/2004 | EP1423134A2 Human secreted proteins |
| 06/02/2004 | EP1423095A1 Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy |
| 06/02/2004 | EP1423012A2 Isolation and mobilization of stem cells expressing vegfr-1 |
| 06/02/2004 | EP1423002A1 Use of cross-linked, covalently bound urokinase plasminogen activator (scupa)-urokinase plasminogen activator receptor (supar) complex as a fibrinolytic agent |
| 06/02/2004 | EP1422991A2 Method for increasing stress tolerance in plants |
| 06/02/2004 | EP1137940A4 Assays for ligands for nuclear receptors |
| 06/02/2004 | EP0981541B1 Psca: prostate stem cell antigen |
| 06/02/2004 | EP0964920A4 Methods for improving seeds |
| 06/02/2004 | EP0941334B1 Protease-activatable pseudomonas exotoxin a-like proproteins |
| 06/02/2004 | EP0870058B1 Use of nucleic acids obtained from the sequence of swine retrovirus |
| 06/02/2004 | EP0807178B1 Mycobacterial proteins, microorganisms producing same and uses of said proteins in vaccines and for detecting tuberculosis |
| 06/02/2004 | EP0792279B1 Antibiotic cryptdin peptides and methods of their use |
| 06/02/2004 | EP0729513B1 Analog of haemophilus hin47 with reduced protease activity |
| 06/02/2004 | EP0724638B1 Avian interferon genes and novel recombinant dna |
| 06/02/2004 | CN1501978A Inducible apomixis |
| 06/02/2004 | CN1501942A Diaryl peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 06/02/2004 | CN1501928A Small molecule compositions for binding to hsp90 |
| 06/02/2004 | CN1501809A Chronic treatment regimen using glucagon-like insulinotropic peptides |
| 06/02/2004 | CN1500876A Full length polynucleotide order of coding fowl ó� type collagen and uses thereof |
| 06/02/2004 | CN1500820A Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| 06/02/2004 | CN1500810A Fibroblast growth factor-2 analogue, producing process and application thereof |
| 06/02/2004 | CN1500809A Fibroblast growth factor-2 analogue, producing process and application thereof |
| 06/02/2004 | CN1500808A Recombination of human soluble TRAIL protein, the preparing method and the application in preparing antineoplastic medicine |
| 06/02/2004 | CN1500807A Method for diagnosing and curing alopecia utilizing the Rhor gene of human and rat and the encoding products |
| 06/02/2004 | CN1500806A HIV-lgp160 membrane protein, preparing method and uses thereof |
| 06/02/2004 | CN1500801A Gene capable of improving the nitrogen fixing ability of combined azotobacter and uses thereof |
| 06/02/2004 | CN1152137C Method for preparing human interleukin 4 using gene engineering and its expression vector and engineering bacterium |
| 06/02/2004 | CN1152052C Process for preparing thymus peptide |
| 06/02/2004 | CN1152051C Trichosanthin mutant and preparing method thereof |
| 06/02/2004 | CN1152047C Process for extracting thallus from waste liquid of monosodium glutamate |
| 06/02/2004 | CN1151841C Application of interferons(IFN) in preparation of pharmaceutics for stimulation of defence mechanism or immune reaction |
| 06/02/2004 | CN1151839C In-colon release-controlled thymopeptide capsule and process for extracting and separating thymopeptide |
| 06/02/2004 | CN1151838C Use of proteins as agents against autoimmune diseases |
| 06/01/2004 | US6743969 Modification of PI-TA gene conferring fungal disease resistance to plants |
| 06/01/2004 | US6743966 Production of membrane proteins in the milk of transgenic mammals |
| 06/01/2004 | US6743908 For use in cancer diagnosis and therapy |
| 06/01/2004 | US6743907 Comprising cub extracellular domain present in bone morphogenetic proteins, proteinases, speradhesins, and neuronal recognition molecules |
| 06/01/2004 | US6743906 For oncology, lung carcinomas; packaged in liposome or retrovirus |
| 06/01/2004 | US6743904 Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof |
| 06/01/2004 | US6743899 Process for inactivating prions in lipoproteins |
| 06/01/2004 | US6743897 Aspergillus fumigatus profilin |
| 06/01/2004 | US6743896 Protien for use in the treatment of infection and tumors |
| 06/01/2004 | US6743895 Bone stimulating factor |
| 06/01/2004 | US6743894 Insulin-like growth factor agonist molecules |
| 06/01/2004 | US6743778 Apo-AI/AII peptide derivatives |
| 06/01/2004 | US6743774 Tribonectins |
| 06/01/2004 | US6743771 For solubilizing a conformationally altered protein, comprising a carboxylic acid anion of picolinic acid, its analogs, or derivatives thereof and a cation; treating alzheimer's disease or creutzfelds-jakob disease for example |
| 06/01/2004 | US6743769 Active against bacteria and fungi that exhibit resistance to multiple current antibiotics; amino acid sequence selected from the group consisting of rp-1 (seq id no: 3), rp-8 (seq id no: 10), rp-11 (seq id no: 13) and rp-13 (seq id no: 14). |
| 06/01/2004 | US6743631 Non-primate mammalian cell lines having no endogenous retroviral sequences for packaging; envelope proteins; gag/pol genes |
| 06/01/2004 | US6743630 Method of preparing a protein array based on biochemical protein-protein interaction |
| 06/01/2004 | US6743628 Comprises neuron differentiation growth factor cultures; for treating neurodegenerative disorders |
| 06/01/2004 | US6743627 Using polyamide nucleic acid oligomers to engender a biological response |
| 06/01/2004 | US6743625 Death domain containing receptor 5 |
| 06/01/2004 | US6743619 For therapeutic, diagnostic and research use |
| 06/01/2004 | US6743613 Nucleotide sequences coding polypeptide for use in the treatment bone and cardiovascular disorders |
| 06/01/2004 | US6743611 For encoding clover yellow vein virus nuclear inclusion-a proteins; proteases; aminopeptidases |
| 06/01/2004 | US6743604 Polypeptides binding human il-13 and/or il-4 cytokines used in medicine, diagnosis and screening for agonists/ antagonists of il-13/il-4 |
| 06/01/2004 | US6743603 Tumor suppressor encoding nucleic acid, PTX1, and methods of use thereof |
| 06/01/2004 | US6743602 For diagnosis and screening |
| 06/01/2004 | US6743600 To yield proteins having their native amino acid sequences; in vitro |
| 06/01/2004 | US6743594 Identifying antagonists and agonists for diagnosis and therapy |
| 06/01/2004 | US6743593 Immunological methodology for discerning human papillomavirus |
| 06/01/2004 | US6743590 Methods for differentiating and monitoring parathyroid and bone status related diseases |
| 06/01/2004 | US6743577 Methods of using cyanovirins to inhibit viral infection |
| 06/01/2004 | US6743431 Capsular polysaccharide adhesin antigen, preparation, purification and use |
| 06/01/2004 | US6743428 Angiogenesis inhibitor |
| 06/01/2004 | US6743427 Prevention and treatment of amyloidogenic disease |
| 06/01/2004 | US6743422 Protein selected from group consisting of residues 66 through 208 of specified amino acid sequence and residues 66 through 208 of same sequence and n-terminal methionine; stimulates production of epithelial cells |
| 06/01/2004 | CA2285058C Coincidence detection method, products and apparatus |
| 06/01/2004 | CA2174231C Process for preparing an inter-alpha-trypsine inhibitor concentrate for therapeutical use, and concentrate thus obtained |
| 06/01/2004 | CA2170605C Mutants of the rb and p53 genes and uses thereof |
| 06/01/2004 | CA2078571C Bacillus thuringiensis cryiiic gene and protein toxic to coleopteran insects |
| 06/01/2004 | CA2034034C Process for the production of antibodies |
| 05/29/2004 | CA2451584A1 Modified cdna factor viii and its derivatives |
| 05/27/2004 | WO2004044838A2 Computer system and methods for producing morphogen analogs of human tdf-1 |
| 05/27/2004 | WO2004044592A1 Diagnostic and therapeutic use of arl7 for alzheimer's disease |
| 05/27/2004 | WO2004044591A2 Use of nuclear hormone receptors to identify meiosis regulating compounds |
| 05/27/2004 | WO2004044587A2 Diagnostics and therapeutics for diseases associated with human endothelial differentiation, sphingolipid g-protein-coupled receptor 5 (edg5) |
| 05/27/2004 | WO2004044580A1 Diagnostics and therapeutics for diseases associated with human endothelial differentiation, lysophosphatidic acid g-protein-coupled receptor 2 (edg2) |
| 05/27/2004 | WO2004044553A2 Lepidoptera voltage-gated calcium channels |
| 05/27/2004 | WO2004044220A2 Flaviviris fusion inhibitors |
| 05/27/2004 | WO2004044217A2 Dna sequences from tcd genomic region of photorhabdus luminescens |
| 05/27/2004 | WO2004044208A2 Food flours with specific technological characteristics and low allergenicity |
| 05/27/2004 | WO2004044206A1 Plasmids expressing human insulin and the preparation method for human insuling thereby |
| 05/27/2004 | WO2004044204A2 Variable fragments of single-chain camelide antibodies and uses thereof for diagnosing and treating various pathologies |
| 05/27/2004 | WO2004044203A1 Fluorescent proteins and chromoproteins from non-aequorea hydrozoa species and methods for using same |
| 05/27/2004 | WO2004044202A1 Method for the gene regulation at both transcription and post-transcription levels |
| 05/27/2004 | WO2004044201A1 Signaling proteins participating in immunopotentiation by virus-origin double-stranded rna and endotoxin and genes thereof |
| 05/27/2004 | WO2004044199A1 Screening method |
| 05/27/2004 | WO2004044197A1 Knock-in mouse prostate cancer model |